Jun Bao
Chief Executive Officer at IMPACT Therapeutics, Inc.
Net worth: 6 943 $ as of 29/04/2024
Profile
Jun Bao is currently the President & Chief Executive Officer at IMPACT Therapeutics, Inc. and the Chairman at BiTech Pharma, Inc. Previously, he held positions such as Associates Director-Business Development at ICOS Corp.
from 2005 to 2006, Director-Development & Financial Planning at Onyx Pharmaceuticals, Inc., Director-Worldwide Business Development at Glaxosmithkline China Ltd.
from 2010 to 2013, Independent Non-Executive Director at Transcenta Holding Ltd.
from 2021 to 2023, Director at Beijing Shenogen Pharma Group Ltd.
from 2013 to 2019, Finance Manager at Procter & Gamble Co. from 1999 to 2001, and Senior Manager-Business Development at CTI BioPharma Corp.
from 2001 to 2005.
Dr. Bao obtained a doctorate degree from the University of Kansas in 1994 and an undergraduate degree from Shandong University in 1986.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 22/08/2023 | 30,000 ( 0.01% ) | 6 943 $ | 29/04/2024 |
Jun Bao active positions
| Companies | Position | Start |
|---|---|---|
BiTech Pharma, Inc.
 BiTech Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services BiTech Pharma, Inc. develops medicines. The private company is based in Emeryville, CA. Xiang Wu Ye has been the CEO of the company since 2008. | Chairman | 02/07/2009 |
IMPACT Therapeutics, Inc.
 IMPACT Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology IMPACT Therapeutics, Inc. manufactures pharmaceutical products. The firm develops discovery and commercialization of novel therapeutics to treat cancer and other life-threatening diseases. The company was founded in 2009 and is headquartered in Nanjing, China. | Chief Executive Officer | 31/08/2018 |
Former positions of Jun Bao
| Companies | Position | End |
|---|---|---|
| TRANSCENTA HOLDING LIMITED | Director/Board Member | 22/08/2023 |
Beijing Shenogen Pharma Group Ltd.
 Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | Director/Board Member | 30/09/2019 |
| Glaxosmithkline China Ltd. | Corporate Officer/Principal | 30/04/2013 |
ICOS Corp.
 ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | Corporate Officer/Principal | 31/12/2005 |
| CTI BIOPHARMA CORP. | Corporate Officer/Principal | 31/01/2005 |
Training of Jun Bao
| The University of Chicago | Masters Business Admin |
| University of Kansas | Doctorate Degree |
| Shandong University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| PROCTER & GAMBLE COMPANY | Consumer Non-Durables |
| TRANSCENTA HOLDING LIMITED | Health Technology |
| Private companies | 7 |
|---|---|
ICOS Corp.
ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | Health Technology |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
CTI BioPharma Corp.
 CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology CTI BioPharma Corp. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. It focuses on evaluating pacritinib, its sole product candidate currently in active development, for the treatment of adult patients with myelofibrosis. The company was founded by James A. Bianco, Jack W. Singer, and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA. | Health Technology |
BiTech Pharma, Inc.
BiTech Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services BiTech Pharma, Inc. develops medicines. The private company is based in Emeryville, CA. Xiang Wu Ye has been the CEO of the company since 2008. | Commercial Services |
| Glaxosmithkline China Ltd. | |
IMPACT Therapeutics, Inc.
IMPACT Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology IMPACT Therapeutics, Inc. manufactures pharmaceutical products. The firm develops discovery and commercialization of novel therapeutics to treat cancer and other life-threatening diseases. The company was founded in 2009 and is headquartered in Nanjing, China. | Health Technology |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | Health Technology |
- Stock Market
- Insiders
- Jun Bao
